INFUSION SITE PLAQUE

This adverse event was reported 23 times

These drugs are most commonly taken by patients reporting INFUSION SITE PLAQUE:

# Drug Count
0 DOCETAXEL 10
1 DOCETAXEL ANHYDROUS 10
2 DEGARELIX 5
3 PREDNISONE 4
4 SODIUM CHLORIDE 4
5 SODIUM CHLORIDE TABLET 4
6 SODIUM CHLORIDE TABLETS 4
7 CALCIUM 3
8 INFLIXIMAB 2
9 INFLIXIMAB-DYYB 2
See all common drugs associated with INFUSION SITE PLAQUE

INFUSION SITE PLAQUE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 DEGARELIX 5 0.0009
1 INFLIXIMAB-DYYB 2 0.0006
2 DOCETAXEL ANHYDROUS 10 0.0001
3 DOCETAXEL 10 0.0001
4 SODIUM CHLORIDE TABLET 4 0.0001
5 SODIUM CHLORIDE TABLETS 4 0.0001
6 SODIUM CHLORIDE 4 0.0000
7 TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% 1 0.0000
8 TRIAMCINOLONE ACETONIDE 1 0.0000
9 POTASSIUM CHLORIDE ORAL 1 0.0000
See all drugs enriched for association with INFUSION SITE PLAQUE

INFUSION SITE PLAQUE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Microtubule Inhibitor [EPC] 11 0.0001
1 Calcium [EPC] 3 0.0000
2 Interleukin-23 Antagonist [EPC] 2 0.0000
3 Osmotic Laxative [EPC] 4 0.0000
4 Alkylating Drug [EPC] 1 0.0000
5 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
6 Corticosteroid [EPC] 5 0.0000
7 Platinum-based Drug [EPC] 1 0.0000
See all drug classes enriched for association with INFUSION SITE PLAQUE